Ista Pharmaceuticals Inc.

ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once-Daily XiDay.
Biotech Week; 12/30/2009; 880 words; ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), announced the Company submitted...Device, Ophthalmic Solution, Pharmaceuticals, Regulatory Actions, Surgery...Drug Administration, Xibrom, ISTA Pharmaceuticals Inc. This article was prepared...

Other News To Note.
BIOWORLD Today; 12/21/2009; 1068 words; o Amgen Inc., of Thousand Oaks...o BioNanomatrix Inc., of Philadelphia...product deliveries. o ISTA Pharmaceuticals Inc., of Irvine, Calif...islets. o Millennium Pharmaceuticals Inc., of Cambridge...Japanese drugmaker Takeda Pharmaceutical Co. Ltd., said that...

ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once-Daily XiDay(TM).
PR Newswire; 12/17/2009; 917 words; ...FirstCall/ -- ISTA Pharmaceuticals, Inc. , today announced...cataract surgery. ISTA currently markets...ISTA Pharmaceuticals ISTA Pharmaceuticals is the fourth largest branded ophthalmic pharmaceutical business in the U...

InSite Vision to Advance New Ocular Anti-Inflammatory Candidate.
Business Wire; 12/15/2009; 1628 words; ...Xibrom[TM], marketed by ISTA Pharmaceuticals) is a topical non-steroidal...development of novel ocular pharmaceutical products based on its DuraSite...Vision's partner, Inspire Pharmaceuticals in the United States. InSite...Bausch & Lomb and Pfizer Inc. InSite Vision's ophthalmic...

ISTA PHARMACEUTICALS FILES 10-Q (QUARTERLY REPORT)
US Fed News Service, Including US State News; 12/3/2009; 285 words; WASHINGTON, Dec. 3 -- ISTA Pharmaceuticals Inc., Irvine, Calif., has filed a Form 10-Q on Nov. 5 for the third quarter ending Sept. 30 with the U.S. Securities and...